Gary Mason MD
Pediatric Neuro-Oncology
Senior Medical Director, Oncology Janssen
Join to View Full Profile
1400 McKean RoadSpring House, PA 19477
Dr. Mason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's National Medical Center/George Washington UniversityFellowship, Pediatric Neuro-Oncology, 2013 - 2014
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2010 - 2013
Brown UniversityResidency, Pediatrics, 2007 - 2010
Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
PA State Medical License 2014 - 2026
DC State Medical License 2013 - 2014
NY State Medical License Active through 2013
American Board of Pediatrics Pediatrics
Clinical Trials
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
- Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
Publications & Presentations
PubMed
- 2 citationsHealth-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and ...Matthew R Smith, Shahneen Sandhu, Daniel J George, Kim Nguyen Chi, Fred Saad
Journal of Managed Care & Specialty Pharmacy. 2023-07-01 - Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report.Javad Nazarian, Gary E Mason, Cheng Ying Ho, Eshini Panditharatna, Madhuri Kambhampati
Oncotarget. 2023-05-12 - 116 citationsNiraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara Jr
The Lancet. Oncology. 2022-03-01
Journal Articles
- Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, Eleni Efstathiou, Gerhardt Attard, David Olmos, Ji Youl Lee, Eric J Small, Andrea J Pereira de Santana Gomes, Guilhem Roubau..., J Clin Oncol ., 3/23/2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
